We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Novartis AG | NYSE:NVS | NYSE | Depository Receipt |
Price Change | % Change | Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.41 | 0.42% | 97.68 | 97.74 | 97.11 | 97.63 | 825,891 | 20:34:51 |
By Sara Sjolin, MarketWatch
LONDON (MarketWatch) -- European stock markets broke a two-day losing streak on Tuesday. Heavyweights such as UBS AG, Novartis AG and BP PLC, which all posted solid quarterly -earnings reports, helped deliver a boost to region's markets.
The broad-based gains came after most European markets slumped on Monday, as banks moved sharply lower, in the wake of stress-test results from the European Central Bank and European Banking Authority. Read: Banks shares catch a cold even after surviving health check
Market reaction: The Stoxx Europe 600 index climbed 1% to close at 328.25 on Tuesday, recovering from a 0.6% slide on Monday.
Germany's DAX 30 index rallied 1.9% to 9,068.19, as all companies in the benchmark closed in positive territory.
France's CAC 40 index added 0.4% to 4,112.67, while the U.K.'s FTSE 100 index rose 0.6% to 6,402.17.
Earnings: Shares of Novartis rose 1.8% after the Swiss drug maker said third-quarter profit jumped 44%.
UBS (UBS) added 5.8% after the Swiss bank reported a rise in third-quarter earnings, although it said it was hit by 1.8 billion Swiss francs ($1.9 billion) in legal provisions.
BP (BP) rose 1.6%, after the energy major said it will raise dividends for the third quarter to 10 cents, a 5.3% increase on the year. The company also said Russia sanctions have had no material impact on the company, although it has felt a squeeze from the falling ruble.
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
1 Year Novartis Chart |
1 Month Novartis Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions